Literature DB >> 18787519

A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men.

Zhenyan Fu1, Tomohiro Nakayama, Naoyuki Sato, Yoichi Izumi, Yuji Kasamaki, Atsushi Shindo, Masakatsu Ohta, Masayoshi Soma, Noriko Aoi, Mikano Sato, Koichi Matsumoto, Yukio Ozawa, Yitong Ma.   

Abstract

BACKGROUND: CYP4F2, a member of the cytochrome P450 family, acts mainly as an enzyme and is involved not only in the metabolism of leukotriene B4, but also in that of arachidonic acid. It converts arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), a metabolite involved in the regulation of the vascular tone in the brain. The aim of this study was to assess the association between the human CYP4F2 gene and cerebral infarction (CI), using a haplotype-based case-control study with separate analyses of data from the gender groups.
METHODS: A total of 175 CI patients and 246 control subjects were genotyped for five single-nucleotide polymorphisms (SNPs) of the human CYP4F2 gene (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200). For data analysis, three separate groups were assessed: all subjects, men, and women.
RESULTS: In the male subjects, the G allele frequency for rs2108622 was significantly higher in CI patients as compared to control subjects (P = 0.025). The overall distribution of the haplotypes in the men was significantly different between the CI patients and the control subjects (P = 0.027). Additionally, the frequency of the T-C-G haplotype for men was significantly higher in the CI patients than in the control subjects (P = 0.008). Multiple logistic regression analysis also revealed the significance of the T-C-G haplotype in men, even after adjustment for confounding factors.
CONCLUSIONS: The results of this study indicate that, in Japanese men, CI is associated with the G allele of rs2108622 and, in addition, that the T-C-G haplotype appears to be a useful genetic marker for CI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787519     DOI: 10.1038/ajh.2008.276

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  20 in total

1.  Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease.

Authors:  Albert W Dreisbach; Stanley V Smith; Patrick B Kyle; Manjunath Ramaiah; Margaret Amenuke; Michael R Garrett; Seth T Lirette; Michael E Griswold; Richard J Roman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-08-22       Impact factor: 3.072

Review 2.  Cytochrome P450 eicosanoids and cerebral vascular function.

Authors:  John D Imig; Alexis N Simpkins; Marija Renic; David R Harder
Journal:  Expert Rev Mol Med       Date:  2011-03-01       Impact factor: 5.600

Review 3.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

4.  Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway.

Authors:  Mei-Hui Hsu; Uzen Savas; Jerome M Lasker; Eric F Johnson
Journal:  J Pharmacol Exp Ther       Date:  2011-01-04       Impact factor: 4.030

5.  Correlation between CYP4F2 gene rs2108622 polymorphism and susceptibility to ischemic stroke.

Authors:  Chong Meng; Juan Wang; Wei-Ning Ge; Shao-Can Tang; Guang-Ming Xu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke.

Authors:  Anjana Munshi; Vandana Sharma; Subhash Kaul; Amal Al-Hazzani; Ali A Alshatwi; Gowhar Shafi; Rajeshwar Koppula; Sai Babu Mallemoggala; A Jyothy
Journal:  Mol Biol Rep       Date:  2011-05-31       Impact factor: 2.316

7.  Cytochrome 4A11 Genetic Polymorphisms Increase Susceptibility to Ischemic Stroke and Associate with Atherothrombotic Events After Stroke in Chinese.

Authors:  Biao Zhang; Xingyang Yi; Chun Wang; Duanxiu Liao; Jing Lin; Lifen Chi
Journal:  Genet Test Mol Biomarkers       Date:  2015-03-03

Review 8.  PharmGKB summary: very important pharmacogene information for CYP4F2.

Authors:  Maria L Alvarellos; Katrin Sangkuhl; Roxana Daneshjou; Michelle Whirl-Carrillo; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-01       Impact factor: 2.089

Review 9.  20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.

Authors:  Jan M Williams; Sydney Murphy; Marilyn Burke; Richard J Roman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

10.  Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level.

Authors:  Duanxiu Liao; Xingyang Yi; Biao Zhang; Qiang Zhou; Jing Lin
Journal:  Genet Test Mol Biomarkers       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.